EUCTR2009-016779-31-DE进行中（未招募）不适用
A Trial Investigating the Pharmacokinetic Properties ofNN5401 in Children, Adolescents and Adults with Type1 Diabetes
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Male or female aged 6-65 years (both inclusive)
- •Type 1 diabetes mellitus (as diagnosed clinically) = 12 months
- •Body mass index for children and adolescents (male and female) between the 3. and 97. BMI percentile and for adults = 30.0 kg/m2.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Subject who has donated any blood or plasma in the past month, or more than
- •500 mL within 3 months prior to screening
- •Not able or willing to refrain from smoking during the inpatient period
- •Female of childbearing potential who is pregnant, breast-feeding or intends to
- •become pregnant or is not using adequate contraceptive methods
研究者
相似试验
进行中（未招募）
不适用
A Trial Investigating the Pharmacokinetic Properties of NN1250 in Children, Adolescents and Adults with Type 1 DiabetesType I diabetes mellitusMedDRA version: 12.0Level: LLTClassification code 10045228Term: Type I diabetes mellitusEUCTR2008-008306-43-DEovo Nordisk A/S
进行中（未招募）
不适用
A trial investigating the pharmacokinetic properties of FIAsp in children, adolescents and adults with type 1 diabetesDiabetes Mellitus, Type 1MedDRA version: 16.0Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861EUCTR2011-002104-32-DEovo Nordisk A/S
进行中（未招募）
不适用
The Pharmacokinetic Study of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin CaDiseases of the circulatory systemKCT0001258Hanlim Pharmaceutical40
已完成
不适用
A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402KCT0003213avipharm38
尚未招募
不适用
A Clinical Trial for Evaluation of Pharmacokinetic interaction between WS1313D and NAC after Co-administration in Healthy Male Adult SubjectsDiseases of the nervous systemKCT0004878Woosung Pharma27